Covered recipient · General Payments record
ROWELLA L SIRBILADZE
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2024
$373.31
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $192.86 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $41.13 | 2 |
| DEXCOM, INC. | $33.02 | 2 |
| Lilly USA, LLC | $28.36 | 1 |
| BETA BIONICS, INC. | $27.77 | 1 |
| Tandem Diabetes Care, Inc. | $26.32 | 2 |
| Novo Nordisk AS | $20.17 | 1 |
| Medtronic, Inc. | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.54 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124895769 | CMS |
| Abbott Laboratories | $24.59 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124895771 | CMS |
| BETA BIONICS, INC. | $27.77 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087888729 | CMS |
| Dexcom, Inc. | $14.92 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153332747 | CMS |
| Dexcom, Inc. | $18.10 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153332749 | CMS |
| Lilly USA, LLC | $28.36 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135339734 | CMS |
| Medtronic, Inc. | $16.09 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117106307 | CMS |
| Novo Nordisk Inc | $20.17 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096708003 | CMS |
| Tandem Diabetes Care, Inc. | $14.20 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138751923 | CMS |
| Tandem Diabetes Care, Inc. | $12.12 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138752005 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.